SC 13G/A

CONSONANCE CAPITAL MANAGEMENT LP

Company: Protalix BioTherapeutics, Inc.
Filed: February 11, 2016
Accession Number: 0001085146-16-002996

View Document ↗ View on SEC.gov ↗